| PLC | primary liver cancer |
| HCC | hepatocellular carcinoma |
| ICC | intrahepatic cholangiocarcinoma |
| CCA | cholangiocarcinoma |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| NAFLD | non-alcoholic fatty liver disease |
| US-FDA | the United States Food and Drug Administration |
| HFD | High-fat diet |
| DEN | Diethylnitrosamine |
| TG | triglyceride |
| NASH | nonalcoholic steatohepatitis |
| HFD | high-fat diet |
| WD | western-style diet |
| PD1 | programmed death-1 |
| CCl4 | carbon tetrachloride |
| STZ | streptozotocin |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| MTDH | metadherin |
| ES | embryonic stem |
| HDTVi | hydrodynamic tail vein injection |
| PTEN | phosphatase and tensin homolog |
| KO | Knockout |
| SB | sleeping beauty |
| HDKO | hepatocyte-specific Traf3/Pten double knockout |
| CDKO | cholangiocyte-specific Traf3/Pten double knockout |
| JNK | c-Jun N-terminal kinase |
| TME | tumor microenvironment |
| CNV | copy number variation |
| TFs | transcription factors |
| YAP | Yes-associated protein |
| CSC | cancer stem cell |
| CAF | cancer-associated fibroblast |
| ECM | extracellular matrix |
| HSC | hepatic stellate cells |
| TCGA | The Cancer Genome Atlas |
| PDXs | Patient-derived tumor xenografts |
| TAMs | tumor-associated macrophages |
| PR | primary resistance |
| NPCs | non-parenchymal cells |
| DHMEQ | Dehydroxymethylepoxyquinomicin |
| MDSC | myeloid-derived suppressor cells |